University of Virginia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Virginia sits in the top decile of US sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count).
University of Virginia: 449 sponsored US clinical trials, 101 recruiting.
University of Virginia sponsors 449 registered US clinical trials on ClinicalTrials.gov, 101 of them currently recruiting, and 281 completed. 40 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 9 trials.
Top-decile sponsor footprint
University of Virginia ranks in the top decile of sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
281 of 317 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
449 total, page 4 of 9
Ketogenic Dietary Patterns in Young Adults and Kidney Health
NCT05350657
High Fat Meal and Postprandial TG Levels With and Without Exercise Intervention
NCT05291767
Effects of Acute Exercise Intensity on Cerebral Blood Flow and Cognitive Function in Older Adults
NCT05131217
Optimizing Efficiency and Impact of Digital Health Interventions for Caregivers
NCT04986904
Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)
NCT05126862
Establishing the Effectiveness of Publicly Available Smoking Cessation Resource
NCT05055778
Effects of Inorganic Nitrate and Intensity of Exercise on Cardiovascular Health in Post-Menopausal Females
NCT05221905
Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients
NCT04376762
Exercise Preconditioning in Ovarian Cancer
NCT05029154
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
NCT04583891
QuitAid Pilot Feasibility Trial
NCT05649241
Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus
NCT05019508
Liposomal Bupivacaine Versus Non-liposomal Bupivacaine for Total Shoulder Arthroplasty
NCT04974385
Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis
NCT04642391
iSIPsmarter: An RCT Evaluating the Efficacy of a Technology-Based Intervention to Reduce Sugary Drinks in Rural Appalachia
NCT05030753
Behavioral Activation for Treatment of Depression in Adolescents With Autism
NCT05018169
Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery
NCT04784637
The Emotional, Physical and Cognitive Benefits of Purposeful Green Space Activities on Seniors
NCT04913363
Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients
NCT04920916
Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation
NCT04877730
Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes
NCT04878120
Telehealth and Meal Replacement Pilot Program for Patients With Diabetes
NCT04885621
Effect of Postprandial Hyperglycemia on Vasculature in Type 1 Diabetes and Healthy Adults
NCT04730882
A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer
NCT04499521
Effectiveness of Exparel TAP Block in Breast Free Flap Reconstruction
NCT04777591
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
NCT04629430
Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes
NCT04665999
Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis
NCT06462885
Fully Automated Closed Loop Control in Adolescents With Type 1 Diabetes
NCT04545567
PENG Block for Arthroscopic Hip Surgery
NCT04508504
Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome
NCT04283292
Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation
NCT04510506
The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication
NCT04632849
Effectiveness of Respiratory Protection During Simulated Resuscitation: a Prospective Cohort Study
NCT04591756
Smartphone Application Smoking Cessation Study
NCT04623736
Effects of Obesity and Intensity of Exercise on Ghrelin Levels
NCT04581980
Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellitus
NCT04439903
The Better Sleep for Supporters With Insomnia Study
NCT04661306
Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes
NCT04443153
Is Topical CBD Effective in Treating Thumb Joint Arthritis
NCT04611347
Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis
NCT04402801
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
NCT04374565
Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic
NCT04368260
Interleukin-5 Receptor Expression in COPD
NCT03984799
Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).
NCT04094064
Gait-Training Using Wearable Sensors
NCT04270565
Inorganic Nitrate: Sex Differences in Muscle Contractile Function and Efficiency
NCT04588740
Impaired Glucose Tolerance and Cognition in MS
NCT04748302
Knee Biofeedback Rehabilitation Interface for Game-based Home Therapy for Patients With Knee Osteoarthritis
NCT04187092
Feasibility of Using Contrast Enhanced Voiding Urosonography (CeVUS) During Urodynamic Studies
NCT04170413
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 58 |
| Phase 2 | 51 |
| Phase 3 | 14 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the University of Virginia pipeline
101 recruiting of 449 indexed (22% open); 281 completed (63%).
Phase mix: 40 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Virginia: open-pipeline peers nationwide
Peers matched on 449 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Virginia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 449 trials (± recruiting share)
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Oklahoma · 22% recruiting · 358 trials
- ALX Oncology · 22% recruiting · 9 trials
Related
What to do with this University of Virginia page
449 registered trials is a research-attention snapshot, not an endorsement of University of Virginia or any single study.
- 101 of University of Virginia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition University of Virginia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Virginia pipeline card: 449 registered trials from official public datasets.Report a data error.